Improvement of arthritis and arthralgia after treatment with infliximab (Remicade) in a German prospective, open-label, multicenter trial in refractory Crohn's disease.
Herfarth
Hans
H
Obermeier
Florian
F
Andus
Tilo
T
Rogler
Gerhard
G
Nikolaus
Susanna
S
Kuehbacher
Tanja
T
Schreiber
Stefan
S
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D018771:Arthralgia / Q000150:complications / Q000175:diagnosis*; D001168:Arthritis / Q000150:complications / Q000175:diagnosis*; D003424:Crohn Disease / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D000069285:Infliximab; D011446:Prospective Studies; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D000911:Antibodies, Monoclonal; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab